These lab-designed options weren't formulated with recreational use in mind. During the nineties, John W. Huffman and also a group of fellow chemists at Clemson College created a number of the initially formulation for artificial cannabinoid receptor agonists (SCRAs), a family of substances that imitate the physiological and psychological impacts o